Skip to main content
UniHealth

Doctor search

John L. Tatman, MD

Gynecologic Oncology · Santa Clara

NPI 1184701021

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • Medicare does not list them as allowed to order and refer

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tatman’s office at (408) 851-1000 to ask if they take your plan before you enroll.

California Medical Board record

Licence G63598 · Current

Licensed to practise in California · since 1988 · expires 2028-07-31 · Ohio State University College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Obstetrics and Gynecology - Gynecologic Oncology

Drugs they prescribed that Part D paid

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 28% of their 87 Part D prescriptions in 2015.

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

Year by year

Part D prescribing by year
20163514NoneNone$2,630
2015873728% (24)None$2,244
20141114432% (35)13%$4,822
20131024228% (28)17%$5,724

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2015: 2 drugs

Part D drugs prescribed in 2015
Ibuprofen23$362$16
Hydrocodone-Acetaminophen21$346$16

2014: 2 drugs

Part D drugs prescribed in 2014
Hydrocodone-Acetaminophen34$384$11
Ibuprofen15$193$13

2013: 1 drug

Part D drugs prescribed in 2013
Hydrocodone-Acetaminophen26$267$10

Money from drug and device companies

$83 in 2024

Industry payments by year
202422None$83
202311None$94

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Merck Sharp & DohmeKeytruda$43
1 payment
  • Meals for Keytruda · 2024-03-17 · $43
GlaxoSmithKlineNone$40
1 payment
  • Meals · 2024-03-16 · $40
See all 2 published payments
Every published payment
Merck Sharp & DohmeMeals · 2024-03-17Keytruda$43
GlaxoSmithKlineMeals · 2024-03-16None$40
See earlier years (2023)

2023: $94

Payments by company in 2023
GlaxoSmithKlineNone$94
1 payment
  • Meals · 2023-06-15 · $94

Professional record

NPI
1184701021
Licence
CA G63598California G63598: Current · expires 2028-07-31
More record details
Sole proprietor
No
Medicaid ID
CA 00G635980
Taxonomy
Federal specialty code 207VX0201X (207VX0201X)
Mailing address
1800 Harrison St Fl 7, Oakland, CA, 94612
NPI first listed
2006-10-31
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.